
Rakesh Kasula
About Rakesh Kasula
Data last updated:
Rakesh Kasula is a Managing Director at Opulant Pharmaceuticals Private Limited (since 2020) and Managing Director at Srizen Pharmaceuticals Private Limited (since 2026). The companies operate in Trading and Pharma. The largest current company by reported revenue is Opulant Pharmaceuticals Private Limited at ₹80.6 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 10 Sep 2020 | 2020 | ₹80.6 Lakh (FY 2023) | Active | |
| Managing Director | 06 Feb 2026 | 2026 | Active |
Board colleagues of Rakesh Kasula
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kasularaghavarao | 08871893 | Opulant Pharmaceuticals Private Limited | Director |
| Gopya Sindhusha Kotari | 11528941 | Srizen Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rakesh Kasula
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rakesh Kasula
Rakesh Kasula currently holds 2 directorships: Opulant Pharmaceuticals Private Limited (Managing Director, since 10 Sep 2020, revenue ₹80.6 Lakh (FY 2023)); Srizen Pharmaceuticals Private Limited (Managing Director, since 06 Feb 2026).
Rakesh Kasula was first appointed on 10 Sep 2020 as Managing Director at Opulant Pharmaceuticals Private Limited. The most recent appointment on record is 06 Feb 2026 at Srizen Pharmaceuticals Private Limited.
The current boards of Rakesh Kasula's companies include Kasularaghavarao (Opulant Pharmaceuticals Private Limited), Gopya Sindhusha Kotari (Srizen Pharmaceuticals Private Limited).